MTI Investee EXOSECT's platform technology receives Animal Health patent

1 October 2014

Exosect Ltd, a leading provider of enabling technologies, has received notification from the UK Patent Office that it has been granted a patent for the control of arthropod infestations for Animal Health using its proprietary technology, Entostat, an electrostatic micro-powder, as a delivery platform for a range of active ingredients.

Read more on the EXOSECT website